Details for Patent: 10,813,921
Which drugs does patent 10,813,921 protect, and when does it expire?
Patent 10,813,921 protects GALAFOLD and is included in one NDA.
This patent has one hundred and fifty-two patent family members in twenty-seven countries.
Summary for Patent: 10,813,921
| Title: | Method to predict response to pharmacological chaperone treatment of diseases |
| Abstract: | The present invention provides methods to determine whether a patient with a lysosomal storage disorder will benefit from treatment with a specific pharmacological chaperone. The present invention exemplifies an in vitro method for determining α-galactosidase A responsiveness to a pharmacological chaperone such as 1-deoxygalactonojirimycin in a cell line expressing a mutant from of α-galactosidase A. The invention also provides a method for diagnosing Fabry disease in patients suspected of having Fabry disease. |
| Inventor(s): | Elfrida Benjamin, Hung V. Do, Xiaoyang Wu, John Flanagan, Brandon Alan Wustman |
| Assignee: | Bpcr LP , Amicus Therapeutics Inc |
| Application Number: | US16/046,247 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,813,921 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,813,921
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amicus Therap Us | GALAFOLD | migalastat hydrochloride | CAPSULE;ORAL | 208623-001 | Aug 10, 2018 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | THE TREATMENT OF FABRY PATIENTS | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,813,921
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 111971 | ⤷ Start Trial | |||
| Argentina | 131106 | ⤷ Start Trial | |||
| Argentina | 131107 | ⤷ Start Trial | |||
| Australia | 2009214648 | ⤷ Start Trial | |||
| Australia | 2014221321 | ⤷ Start Trial | |||
| Australia | 2016206297 | ⤷ Start Trial | |||
| Australia | 2017268649 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
